Pressmeddelande

BioStock: Orion option exercise triggers milestone payment for Alligator

Cision Publicerad: 02 May 08:57

The collaboration between Alligator Bioscience and the global pharma company Orion Corporation continues to bear fruit. Orion has chosen to exercise its option to develop new antibody cancer therapeutics leveraging Alligator’s antibody discovery technologies and RUBY bispecific format.

– With this option exercise, we believe Orion has selected considerably differentiated bispecific antibodies that could lead to highly innovative treatments, says Alligator’s CEO Søren Bregenholt.

Read the article at biostock.se:

Orion option exercise triggers milestone payment for Alligator - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Alligator Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!